Sabrina Uhrig
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry.
Journal: NPJ breast cancer
Published: November 29, 2025
Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial.
Journal: Breast cancer research and treatment
Published: October 24, 2025
Standardized patient coaching improves therapy persistence in patients with hormone receptor-positive, HER2-negative advanced/metastatic breast cancer treated with abemaciclib.
Journal: Breast (Edinburgh, Scotland)
Published: July 14, 2025
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 05, 2025
Overall Survival in Metastatic Breast Cancer Patients: Real-World Data from 1,000 Patients Treated at the NCT Heidelberg between 2014 and 2022.
Journal: Breast care (Basel, Switzerland)
Published: May 22, 2025
Adherence to digital pregnancy care - lessons learned from the SMART start feasibility study.
Journal: NPJ digital medicine
Published: May 08, 2025
The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study.
Journal: Journal of cancer research and clinical oncology
Published: February 13, 2025
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk.
Journal: Breast (Edinburgh, Scotland)
Published: December 23, 2024
Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionality.
Journal: BMC immunology
Published: November 28, 2024
Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact.
Journal: Precision clinical medicine
Published: September 22, 2024
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.
Journal: International journal of cancer
Published: September 20, 2024
A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility Study.
Journal: JMIR cancer
Published: July 15, 2024
Last Updated: 09/26/2026